<p>Ht-29 cells were treated with increasing concentrations of oxaliplatin (1–300 µM) in the presence or in the absence of 10 µM rosiglitazone. Incubation was allowed for 48 h. Cell viability was measured by MTT assay. Control condition was arbitrarily set as 100% and values are expressed as the mean ± S.E.M. of three experiments. *P<0.05 and **P<0.01 in comparison to control (oxaliplatin 0 µM).</p
A) Dose-response curves of cell viability in the parental HCT116 cells, HCT116/OX-R4.3, and HCT116/O...
<p>(<b>A</b>) COLO 320 DM cells were treated with a range of Oxaliplatin (0.005–0.1 mM) or 5-Fluorou...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>HT-29 cells were treated with increasing concentrations of oxaliplatin (1–100 μM) in the presence...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed 24 h to oxaliplatin (OXA) (2–200 µM). Cell viabi...
<p>Cultured PC12 cells were incubated with oxaliplatin (3 μM) for 24 h in the presence or absence of...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed for 24 h to oxaliplatin (OXA) (50, 100 or 200 µM...
<p>HNGC-2 cells were treated for 24 h with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide,...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...
<p>Viability was evaluated both by membrane integrity using neutral red test and mitochondrial metab...
<p>A) HT29 and RHT29 cells were subcutaneously inoculated into nude mice. Two weeks later, animals w...
<p>C-26 cells were incubated with oxaliplatin (70 μM) for 24 h in the presence or absence of exenati...
<p>A) The effect of oxaliplatin on the viability of human colorectal cancer cells. Caco-2, SW1116 an...
A) Dose-response curves of cell viability in the parental HCT116 cells, HCT116/OX-R4.3, and HCT116/O...
<p>A–C, MTS assay in HCT116 (<i>MLH1−/MSH3−</i>), HCT116+3 (<i>MLH1+/MSH3−</i>), and HCT116+3+5 (<i>...
A) Dose-response curves of cell viability in the parental HCT116 cells, HCT116/OX-R4.3, and HCT116/O...
<p>(<b>A</b>) COLO 320 DM cells were treated with a range of Oxaliplatin (0.005–0.1 mM) or 5-Fluorou...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>HT-29 cells were treated with increasing concentrations of oxaliplatin (1–100 μM) in the presence...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed 24 h to oxaliplatin (OXA) (2–200 µM). Cell viabi...
<p>Cultured PC12 cells were incubated with oxaliplatin (3 μM) for 24 h in the presence or absence of...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed for 24 h to oxaliplatin (OXA) (50, 100 or 200 µM...
<p>HNGC-2 cells were treated for 24 h with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide,...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...
<p>Viability was evaluated both by membrane integrity using neutral red test and mitochondrial metab...
<p>A) HT29 and RHT29 cells were subcutaneously inoculated into nude mice. Two weeks later, animals w...
<p>C-26 cells were incubated with oxaliplatin (70 μM) for 24 h in the presence or absence of exenati...
<p>A) The effect of oxaliplatin on the viability of human colorectal cancer cells. Caco-2, SW1116 an...
A) Dose-response curves of cell viability in the parental HCT116 cells, HCT116/OX-R4.3, and HCT116/O...
<p>A–C, MTS assay in HCT116 (<i>MLH1−/MSH3−</i>), HCT116+3 (<i>MLH1+/MSH3−</i>), and HCT116+3+5 (<i>...
A) Dose-response curves of cell viability in the parental HCT116 cells, HCT116/OX-R4.3, and HCT116/O...
<p>(<b>A</b>) COLO 320 DM cells were treated with a range of Oxaliplatin (0.005–0.1 mM) or 5-Fluorou...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...